Home Dental Radiology A case-control study of topical and supplemental fluoride use and osteosarcoma risk

A case-control study of topical and supplemental fluoride use and osteosarcoma risk

by adminjay


The National Osteosarcoma Etiology Group is represented by MA Simon (University of Chicago, Chicago, IL), MC Gebhardt (Massachusetts General Hospital, Boston, MA), MT Scarborough (Shands Medical Center, University of Florida, Gainesville, FL), S Gitelis (Rush Presbyterian and St. Luke’s Medical Center, Chicago IL), JJ Eckardt (UCLA School of Medicine, Los Angeles, CA), JR Neff (Nebraska Health System, Omaha, NE), MJ Joyce (Cleveland Clinic Foundation, Cleveland, OH), M McGuire (Creighton University, Omaha, NE), and HC Anderson (University of Kansas Medical Center, Kansas City, KS).

Disclosures. Dr. Douglass has written reviews of the literature for a number of companies that sell, reimburse, or do research on preventive dentistry products, most notably GlaxoSmithKline, Colgate-Palmolive, Henry Schein, Dentsply, Quintiles, and Delta Dental Plans, as well as the US Public Health Service. Dr. Hayes has done limited consulting with Proctor & Gamble. None of the other authors reported any disclosures.

Statistical analysis for this study was conducted by the Collaborative Studies Coordinating Center, University of North Carolina at Chapel Hill, with funding from CDI Research. Data collection for this study was conducted by Westat, with Dr. Robert Hoover as principal investigator.

The authors acknowledge the participation of the patients, hospitals, and surgeons in this study.

Phase 1 of this study was funded by grant 5R01ESO6000 from the National Institute of Environmental Health Sciences, National Institutes of Health . Data collection was conducted by the New England Research Institute. Phase 2 was funded by grant T32DE07151 from the National Cancer Institute and the National Institute of Dental and Craniofacial Research , National Institutes of Health.

Source link

Related Articles

Leave a Comment